SAM #NOI-NIAID-26-2280298

Sole Source Procurement of SomaScan 7K and 11K Assay Kits for NIH Clinical Research

This opportunity involves a sole source procurement by the National Institute of Allergy and Infectious Diseases (NIAID) for SomaScan 7K and 11K assay kits from SomaLogic Operating Co, Inc. These kits are essential for high-throughput, multiplexed protein analysis in clinical samples supporting NIH research. - Agency: National Institute of Allergy and Infectious Diseases (NIAID), NIH, HHS - Sole source procurement to SomaLogic Operating Co, Inc. - Products: 15 SomaScan 7K and 11K assay kits - Kits support analysis of serum, plasma, cell lysates, tissue homogenates, urine, and cerebrospinal fluid - Each kit measures up to 11,000 proteins with high accuracy and low sample volume - Part numbers include 900-00020, 900-200021, 900-00026, 900-00025, 900-00027, 900-00050, 900-00051, 900-00055, 900-00057 - No substitutions allowed; only SomaLogic kits are acceptable - Period of performance: March 1, 2026 to June 30, 2026 (4 months) - Estimated contract value: $522,030 - Delivery and place of performance: NIH facilities in Bethesda, MD - Justification: Unique capabilities and data comparability requirements; delays would impact ongoing clinical trials and research

Description

THIS IS A NOTICE OF INTENT AND NOT A REQUEST FOR QUOTATIONS. This notice is published in accordance with Federal Acquisition Regulation (FAR) 5.101(a)(1) requiring the dissemination of information regarding proposed contract actions. This is a Notice of Intent to award a sole source, firm-fixed price purchase order under the authority of 41 U.S.C. 3304(a)(1), as implemented by FAR 13.106-1(b)(2) and 13.501(a) - Only One Responsible Source and No Other Supplies or Service Will Satisfy Agency Requirements and is not a request for competitive proposals.

The National Institute of Allergy and Infectious Diseases (NIAID) intends to negotiate on a sole source basis with SomaLogic Operating Co, Inc, 2945 Wilderness Place, Boulder, CO 80301 on an other than full and open competition basis to obtain SomaScan 7KPlasma (900-00020), Serum (900-200021), Urine (900-00026), Cerebral Spinal Fluid (900-00025), Cell and Tissue Kits (900-00027) and/or 11K Plasma (900-00050), Serum (900-00051), CSF (900-00055), Cell and Tissue (900-00057) Assay Kits. QTY 15. Only one award will be made. This will be awarded as a firm fixed price type of contract. SomaLogic, SOMAscan Kits can only be provided by one source. 20 Domestic Shipping and Handling – FOB DESTINATION TO BETHESDA, MD.

Justification: This experiment is dependent on the results of the current sample batching experiment that is currently occurring at the CHI. These items should be placed on a PO with a period of performance of one year. This will allow our researchers to request delivery of the items once the batching experiment is complete. Any procurement delays would catastrophic to this experiment. Additionally if the sample batching experiment needs adjustments and is delayed having these somascan kits on-hand would cause them to expire. The purpose of this acquisition is to purchase 15 SomaScan 7K and 11K assay kits for the Center for Human Immunology (CHI) for the ability to analyze clinical samples (serum, plasma, cell lysates, tissue homogenates, urine, and cerebrospinal fluid) with highly multiplexed analytes and high throughput proteins. The kits will be used to measure 11,000 proteins across 10 logs of concentration dynamic range in less than 150 uL of human biological samples with median %CV<5% across all analytes. Currently, there are numerous CHI projects and NIH fee-for-service customers from various institutes and centers in the NIH Intramural Research Program (IRP) that are awaiting their samples to be run on the platform for their clinical protocols.

This will be the only notice of the Government's intent to solicit, negotiate, and award to one source to satisfy this requirement. The Government plans to award a contract for this requirement within 7 days of this notice. The statutory authority for this sole source requirement is 41 U.S.C. 253(c)(1) as implemented by FAR 6.302-1 (b)(1)(i) only one source available, no substitutions possible. THIS IS NOT A SOLICITATION FOR COMPETITIVE QUOTATIONS All responsible sources that could provide comparable services may submit a capability statement that will be considered by email to Jessica Emerson at Jessica.emerson@nih.gov by 5:00 pm EST on May 13, 2026. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. Any responses received by NIAID after this date and exact time specified are late and will not be considered. This notice does not obligate the Government to award a contract or otherwise pay for any information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that it’s sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. For additional information or to submit responses, please contact Linda Smith, Contracting Officer at Linda.smith2@nih.gov or Jessica Emerson, Procurement Technician at Jessica.emerson@nih.gov

View original listing